Evaluation of Rituximab in Systemic Sclerosis Associated Polyarthritis
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Polyarthritis
- Focus Therapeutic Use
- Acronyms RECOVER
- 02 Mar 2018 Biomarkers information updated
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Feb 2013 Planned initiation date changed from 1 Jan 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.